Publication, Part of Case-mix Adjusted Percentage of Cancers Diagnosed at Stages 1 and 2 in England
Case-mix adjusted percentage of cancers diagnosed at stages 1 and 2 in England, 2020
Official statistics
Correction to data tables.
In Table 5, the previous publications data was also included. This has now been removed and corrected data tables have been uploaded.
Please accept our apologies for any inconvenience caused.
15 December 2022 14:55 PM
Unadjusted percentage of cancers diagnosed at stages 1 and 2 by cancer site/group and deprivation, 2020
Cancer site/group
Table 1 lists the unadjusted percentage of cancers diagnoses at stages 1 and 2 by cancer site/group in 2020. Of the cancer sites/groups listed, the percentage of cases diagnosed at stages 1 and 2 ranged from 19% (oesophagus including cardia and gastroesophageal junction) to 91% (testis).
The percentage of cancers diagnosed at stages 1 and 2 may vary by cancer site/group for several reasons. These reasons include: patient awareness and recognition of symptoms, the ease of diagnosis of the symptoms by healthcare practitioners (cancers with non-specific symptoms can be harder to diagnose), and how fast the cancer spreads and develops.
Table 1. Unadjusted percentage of cancers diagnosed at stages 1 and 2 by cancer site/group (2020)
|
Cancer site/group |
Number of cancers diagnosed at stages 1 and 2 |
Total number of stageable cancers diagnosed |
Percentage diagnosed at stages 1 and 2 (%) |
|
Testis |
1,387 |
1,528 |
91 |
|
Melanoma of skin |
9,548 |
10,975 |
87 |
|
Breast |
28,229 |
34,107 |
83 |
|
Uterus |
5,060 |
6,440 |
79 |
|
Bladder |
4,808 |
6,706 |
72 |
|
Kidney, except renal pelvis |
3,983 |
7,064 |
56 |
|
Oropharynx, base of tongue, tonsil, soft palate, and uvula |
1,732 |
3,269 |
53 |
|
Prostate |
15,468 |
30,301 |
51 |
|
Larynx including anterior surface of epiglottis |
649 |
1,303 |
50 |
|
Hodgkin lymphoma |
639 |
1,422 |
45 |
|
Colon |
9,009 |
20,203 |
45 |
|
Rectum and rectosigmoid junction |
3,826 |
9,467 |
40 |
|
Oral cavity, hard palate and lip (inner aspect) |
952 |
2,409 |
40 |
|
Ovary, fallopian tube and primary peritoneal carcinomas |
1,845 |
4,861 |
38 |
|
Lung |
9,898 |
33,581 |
29 |
|
Non-Hodgkin lymphoma |
2,245 |
8,175 |
27 |
|
Pancreas |
1,751 |
7,045 |
25 |
|
Oesophagus including cardia and gastroesophageal junction |
1,236 |
6,648 |
19 |
Deprivation
All stageable cancers are included within this section, this includes the 18 cancer sites/groups in Table 1 plus other stageable cancer sites defined according to the United Kingdom and Ireland Association of Cancer Registries (UKIACR).
Table 2 shows that the unadjusted percentage of cancers diagnosed at stages 1 and 2 varies by deprivation quintile for England. In 2020, the percentage of cancers diagnosed at stages 1 and 2 in the 20% most deprived areas of England is 7 percentage points lower than for those in the 20% least deprived areas (47% versus 55%), this is significantly lower.
Table 2. Unadjusted percentage of cancers diagnosed at stages 1 and 2 by deprivation (2020)
|
Deprivation Quintile |
Number of cancers diagnosed at stages 1 and 2 |
Total number of stageable cancers diagnosed |
Percentage diagnosed at stages 1 and 2 (%) |
|
5 – least deprived |
25,258 |
46,186 |
55 |
|
4 |
24,658 |
46,496 |
53 |
|
3 |
23,214 |
44,611 |
52 |
|
2 |
20,247 |
40,404 |
50 |
|
1 – most deprived |
18,266 |
38,560 |
47 |
Cancer site/group and deprivation
Table 3 shows that of the 18 cancer sites/groups investigated, 9 had a significantly lower percentage of cancers diagnosed at stages 1 and 2 in the 20% most deprived areas compared to those in the 20% least deprived areas, 1 was significantly higher and 8 cancer sites/groups had no significant difference.
Table 3. Unadjusted percentage of cancers diagnosed at stages 1 and 2 by cancer site/group and deprivation (2020)
|
Cancer site/group |
Percentage of cancers diagnosed at stages 1 and 2 in most deprived quintile |
Percentage of cancers diagnosed at stages 1 and 2 in least deprived quintile |
Statistically significant difference? |
|
Bladder |
69 |
74 |
Yes |
|
Breast |
81 |
85 |
Yes |
|
Colon |
42 |
45 |
Yes |
|
Hodgkin lymphoma |
45 |
45 |
No |
|
Kidney, except renal pelvis |
58 |
54 |
Yes |
|
Larynx including anterior surface of epiglottis |
38 |
60 |
Yes |
|
Lung |
29 |
30 |
No |
|
Melanoma of skin |
85 |
88 |
Yes |
|
Non-Hodgkin lymphoma |
28 |
28 |
No |
|
Oesophagus including cardia and gastroesophageal junction |
19 |
19 |
No |
|
Oral cavity, hard palate and lip (inner aspect) |
40 |
44 |
No |
|
Oropharynx, base of tongue, tonsil, soft palate and uvula |
43 |
62 |
Yes |
|
Ovary, fallopian tube and primary peritoneal carcinomas |
40 |
38 |
No |
|
Pancreas |
23 |
25 |
No |
|
Prostate |
49 |
52 |
Yes |
|
Rectum and rectosigmoid junction |
36 |
43 |
Yes |
|
Testis |
91 |
93 |
No |
|
Uterus |
77 |
80 |
Yes |
Last edited: 2 August 2023 4:40 pm